19.8.10    Unsupervised or Take-Home Use.  The OTP shall develop and follow policies and procedures regarding take-home privileges.  The policy shall ensure the following:19.8.10.1    All decisions regarding take-home privileges shall be documented in the client record and shall comply with the requirements cited in 42 CFR Chapter 1, Subchapter A, Part 8.19.8.10.2    Medication shall be dispensed only in oral form.19.8.10.2.1    Methadone shall be dispensed in liquid form only in single dose containers, or in dry form only in multiple dose containers.19.8.10.2.2    Other medications shall be dispensed according to federal regulations and manufacturer's recommendation.19.8.10.3    Clients will not be allowed take-home privileges during the first ninety (90) continuous days of treatment.19.8.10.4    After ninety (90) continuous days of treatment, clients may be allowed take-home privileges no greater than the following schedule:19.8.10.4.1    From the ninety first (91st) to the one hundred eightieth (180th) continuous days of treatment, one take-home dose per week is permitted;19.8.10.4.2    From the one hundred eighty first (181st) to the two hundred seventieth (270th) continuous days of treatment, two take-home doses per week are permitted;19.8.10.4.3    From the two hundred seventy first (271st) to the three hundred sixtieth (360th ) continuous days of treatment, three take-home doses per week are permitted;19.8.10.4.4    From the, three hundred sixty first (361st) continuous day of treatment onward, six take-home doses per week are permitted. see full law